Please provide your email address to receive an email when new articles are posted on . Six months of azithromycin maintenance therapy reduced the rate of respiratory exacerbations and pathogenic ...
Please provide your email address to receive an email when new articles are posted on . Long-term azithromycin treatment increased lumen radius and lumen area in patients with severe persistent asthma ...
April 24, 2009 (Paris, France) — In the never-ending search for therapies to prevent chronic lung allograft rejection, macrolide antibiotics, such as azithromycin, show promise, but only in about half ...
Azithromycin can cause side effects that range from mild to serious. More common side effects include nausea, vomiting, and abdominal pain. If azithromycin’s side effects become difficult to tolerate, ...
The guideline from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) does not recommend antibiotics for prevention of COPD exacerbations. Citing decades-old data on the lack of ...
BOS may be the result of immunologic injury targeting both endothelial and epithelial tissues in the pulmonary system, and such immunologic damage may represent cGVHD, or can be induced and aggravated ...
May 24, 2011 (Denver, Colorado) — The addition of daily azithromycin to conventional treatment for chronic obstructive pulmonary disease (COPD) significantly helps reduce acute exacerbations ...
Bronchiolitis obliterans syndrome (BOS), defined as new fixed airflow obstruction that develops in the setting of active chronic GVHD (cGVHD), is a serious and ...
This leaflet answers some common questions about AZITHROMYCIN VIATRIS. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All ...
Epidemiologic, laboratory, animal, and clinical studies suggest that there is an association between Chlamydia pneumoniae infection and atherogenesis. We evaluated the efficacy of one year of ...
Although several macrolide antibiotics are proarrhythmic and associated with an increased risk of sudden cardiac death, azithromycin is thought to have minimal cardiotoxicity. However, published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results